SEC Form 4 · accession 0001127602-15-012131

ALLERGAN INC · AGN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Deborah Dunsire

Director

Period of report

Mar 17, 2015

Accepted (ET)

Mar 19, 2015 · 7:41 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000850693

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Mar 17, 2015	M	8,860	—	A	43,041	D
Common Stock^F2,F3	Mar 17, 2015	D	43,041	—	D	0	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Phantom Stock Units^F1	—	Mar 17, 2015	M	8,860	D	Mar 17, 2015	Mar 17, 2015	Common Stock	8,860	D
Nonemployee Director Stock Option (Right to Buy)^F4,F5	$60.60	Mar 17, 2015	D	11,400	D	—	May 1, 2017	Common Stock	11,400	I
Nonemployee Director Stock Option (Right to Buy)^F5	$54.32	Mar 17, 2015	D	11,400	D	—	May 6, 2018	Common Stock	11,400	I
Nonemployee Director Stock Option (Right to Buy)^F5	$46.66	Mar 17, 2015	D	11,400	D	—	Apr 30, 2019	Common Stock	11,400	I
Nonemployee Director Stock Option (Right to Buy)^F5	$61.98	Mar 17, 2015	D	11,400	D	—	Apr 29, 2020	Common Stock	11,400	I
Nonemployee Director Stock Option (Right to Buy)^F5	$113.55	Mar 17, 2015	D	5,355	D	—	Apr 30, 2023	Common Stock	5,355	D

Explanation of responses

F1Each phantom stock unit ("PSU") was the economic equivalent of one share of the Issuer's common stock. Each PSU settled in full on the Effective date (as define below) in connection with the reporting person's termination of service. The amount shown includes shares acquired pursuant to dividend rights attached to each PSU.
F2Pursuant to that certain Agreement and Plan of Merger dated November 16, 2014, (the "Merger Agreement") by and among the Issuer, Actavis, Plc ("Actavis) and a wholly-owned subsidiary of Actavis, the Issuer became an indirect wholly-owned subsidiary of Actavis upon consummation of the merger (the "Effective Date"). Each share of common stock was disposed of in exchange for $129.22 cash plus 0.3683 of an Actavis ordinary share, having a market value of $307.51 per share on the Effective Date.
F3The number of shares reported on this line item includes shares acquired pursuant to dividend rights attached to restricted stock units that were previously granted and reported as Table 1, Non-Derivative Securities.
F4The option was previously reported as covering 5,700 shares at an exercise price of $121.20. The issuer effected a two-for-one stock split on June 22, 2007, which resulted in 11,400 shares held by the reporting person at an exercise price of $60.60.
F5Each option vested in full on the Effective Date and was cancelled in exchange for a cash payment equal to the number of shares subject to the option immediately prior to the merger, multiplied by the difference between (i) 0.3683 times $294.1509 (which represents the 10-day volume weighted average price of Actavis stock starting on the 11th trading day prior to the closing) plus $129.22 and (ii) the exercise price of the option, subject to the applicable withholding taxes and pursuant to the procedures set forth in the Merger Agreement.